Please Wait
Applying Filters...
menu
    • menu
    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    USP reference standards; highly characterized specimens of drug substances, impurities, excipients, degradation products & more.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    Guizhou Utide Biotechnology Co., Ltd. - Specialized GMP manufacturing for next-generation GLP-1 peptide APIs.

    Virtual Booth

    Contact Supplier

    Menu

    Ratutrelvir

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Traws Pharma Reviews Ratutrelvir COVID-19 Study
    Traws Pharma Reviews Ratutrelvir COVID-19 Study

    19 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/19/3240994/0/en/Traws-Pharma-Completes-Analysis-of-Ratutrelvir-Clinical-Study-in-PAXLOVID-Eligible-and-Ineligible-COVID-19-Patients-and-Provides-Updates-for-Additional-Indication-for-Tivoxavir-Mar.html

    GLOBENEWSWIRE
    19 Feb 2026
    Share Share
    Traws Pharma Completes Enrollment in Ratutrelvir COVID-19 Trial
    Traws Pharma Completes Enrollment in Ratutrelvir COVID-19 Trial

    26 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/26/3225645/0/en/Traws-Pharma-Completes-Enrollment-of-Ratutrelvir-Clinical-Study-in-PAXLOVID-Eligible-and-Ineligible-COVID-19-Patients-Announces-Plans-for-Added-Indication-for-Tivoxavir-Marboxil-as.html

    GLOBENEWSWIRE
    26 Jan 2026
    Share Share
    Traws Files IND for Tivoxavir Marboxil in Influenza Therapy
    Traws Files IND for Tivoxavir Marboxil in Influenza Therapy

    13 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/13/3217637/0/en/Traws-Pharma-Files-Tivoxavir-Marboxil-Investigational-New-Drug-IND-Application-for-Influenza-Therapy-and-Provides-Updated-Results-from-the-Ongoing-Clinical-Study-of-Ratutrelvir-in-.html

    GLOBENEWSWIRE
    13 Jan 2026
    Share Share
    Traws Pharma: Positive Interim Data with Ratutrelvir vs. PAXLOVID
    Traws Pharma: Positive Interim Data with Ratutrelvir vs. PAXLOVID

    17 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/17/3206814/0/en/Traws-Pharma-Reports-Positive-Interim-Clinical-Data-with-Ratutrelvir-Versus-PAXLOVID-Shows-Activity-in-PAXLOVID-Ineligible-COVID-19-Patients.html

    GLOBENEWSWIRE
    17 Dec 2025
    Share Share
    ChemDiv Extends CMC Collaboration For Ratutrelvir In Ph 2 Trial
    ChemDiv Extends CMC Collaboration For Ratutrelvir In Ph 2 Trial

    30 Oct 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/chemdiv-extends-cmc-services-collaboration-for-ratutrelvir-a-potential-best-in-class-covid-19-therapeutic-advancing-in-phase-2-clinical-trials-302599828.html

    PR NEWSWIRE
    30 Oct 2025
    Share Share
    Expert Systems Backs Traws Pharma's Ratutrelvir Phase 2 COVID-19
    Expert Systems Backs Traws Pharma's Ratutrelvir Phase 2 COVID-19

    22 Oct 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/dover-delaware--expert-systems-inc-a-leading-life-sciences-accelerator-supports-traws-pharma-phase-2-clinical-studies-of-ratutrelvir--a-novel-ritonavir-free-antiviral-for-covid-19-302592063.html

    PR NEWSWIRE
    22 Oct 2025
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.